Zobrazeno 1 - 10
of 14
pro vyhledávání: '"оксаліплатин"'
Оксаліплатин є препаратом вибору у пацієнтів із злоякісними пухлинами шлунково-кишкового тракту. Проте, при проведенні хіміотерапії ок
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2001::cbd98353dda6f49dbed226ccfd95c0ae
http://essuir.sumdu.edu.ua/handle/123456789/57998
http://essuir.sumdu.edu.ua/handle/123456789/57998
Publikováno v:
Vìsnik farmacìï. :34-37
The fight against cancer diseases is one of the most urgent problems of modern pharmacy. One of the basic standards of treatment is surgery in order to remove tumours with chemotherapeutic agents for suppression of disease manifestations. One of the
Publikováno v:
ScienceRise: Pharmaceutical Science, Vol 0, Iss 6 (10), Pp 21-25 (2017)
ScienceRise: Pharmaceutical Science; № 6 (10) (2017); 21-25
ScienceRise: Pharmaceutical Science; № 6 (10) (2017); 21-25
Lyophilization is one of the most prospective and technologically logical methods for preserving the structure of nanobiotechnological products. Liposomes with oxaliplatin were obtained, and a screening experiment was performed to select a cryoprotec
Publikováno v:
Ukraïns’kij bìofarmacevtičnij žurnal. :24-28
At present, there is an increasing interest in developing new ways of drug delivery and targeted therapy, using nanotechnology and nanomaterials. Aim – to study the order of carrying out of pharmaceutical development of liposoms with cytostatics. P
Publikováno v:
Фармацевтичний часопис, Vol 0, Iss 1 (2018)
The development of medicines of a nanoscale diapason opens a new trend in the modern pharmaceutical industry. Reducing the toxicity of known cytotoxic agents is one of the advantages of the liposomal biotechnology platform. The aim of the work is to
Publikováno v:
Вісник фармації; № 4(88) (2016): Вісник фармації; 34-37
Vìsnik farmacìï; № 4(88) (2016): Vìsnik farmacìï; 34-37
Вестник фармации; № 4(88) (2016): Вестник фармации; 34-37
Vìsnik farmacìï; № 4(88) (2016): Vìsnik farmacìï; 34-37
Вестник фармации; № 4(88) (2016): Вестник фармации; 34-37
The fight against cancer diseases is one of the most urgent problems of modern pharmacy. One of the basic standards of treatment is surgery in order to remove tumours with chemotherapeutic agents for suppression of disease manifestations. One of the
Publikováno v:
Український біофармацевтичний журнал; № 6(53) (2017): Український біофармацевтичний журнал; 24-28
Ukraïns’kij bìofarmacevtičnij žurnal; № 6(53) (2017): Ukraïns’kij bìofarmacevtičnij žurnal; 24-28
Украинский биофармацевтический журнал; № 6(53) (2017): Украинский биофармацевтический журнал; 24-28
Ukraïns’kij bìofarmacevtičnij žurnal; № 6(53) (2017): Ukraïns’kij bìofarmacevtičnij žurnal; 24-28
Украинский биофармацевтический журнал; № 6(53) (2017): Украинский биофармацевтический журнал; 24-28
At present, there is an increasing interest in developing new ways of drug delivery and targeted therapy, using nanotechnology and nanomaterials.Aim – to study the order of carrying out of pharmaceutical development of liposoms with cytostatics. Pr
Lyophilization is one of the most prospective and technologically logical methods for preserving the structure of nanobiotechnological products. Liposomes with oxaliplatin were obtained, and a screening experiment was performed to select a cryoprotec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3033::2598c791e9e85137fb8464dc5ff69687
http://repository.kpi.kharkov.ua/handle/KhPI-Press/34214
http://repository.kpi.kharkov.ua/handle/KhPI-Press/34214
Publikováno v:
Gastroenterologia (2308-2097); 2022, Vol. 56 Issue 3, p179-189, 11p
Publikováno v:
Klinichna Khirurhiya / Ministerstvo Okhorony Zdorov'ia Ukraïny, Naukove Tovarystvo Khirurhiv Ukraïny; jan2019, Vol. 86 Issue 1, p69-72, 4p